| Zeit | Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| 13.11.23 | Regional REIT - Underlying progress but leasing remains subdued | 171 | Edison Investment Research | Regional REIT's (RGL's) Q323 trading update includes details of further leasing events, at rents ahead of market levels, and continuing asset sales, at or above book value. However, with the balance... ► Artikel lesen | |
| 13.11.23 | BlackRock Latin American Investment Trust - Last man standing - committed to the region | 265 | Edison Investment Research | BlackRock Latin American Investment Trust (BRLA) has two managers, Sam Vecht (lead) and Christoph Brinkmann (deputy). They highlight that Latin America has been overlooked by investors and the trust... ► Artikel lesen | |
| 13.11.23 | Team Internet Group - Diversity delivering resilience | 229 | Edison Investment Research | Team Internet's results for the nine months to 31 September 2023 (9M23) showed good, continued progress, with revenue, adjusted EBITDA and adjusted EPS growing 16%, 11% and 28% y-o-y. Online Presence... ► Artikel lesen | |
| 13.11.23 | Molten Ventures - NAV down c 6% in the first half of FY24 | 266 | Edison Investment Research | Molten Ventures released its H124 trading update (to end-September 2023), with management expecting its NAV per share at c 735p, a c 5.7% decline from the end-March 2023 level as a result of a 3.6%... ► Artikel lesen | |
| 13.11.23 | EQS Group - New customer numbers ramp up | 445 | Edison Investment Research | As anticipated, now that the German whistleblower protection laws are in place, EQS is recruiting substantial numbers of new customers and is set for a strong fourth quarter, with good momentum into... ► Artikel lesen | |
| 13.11.23 | Mendus - Guarding against relapse | 318 | Edison Investment Research | Mendus's Q323 update was primarily focused on the clinical progression of its lead cancer vaccine, vididencel, which is being developed for acute myeloid leukaemia (AML) and ovarian cancer (OC). The... ► Artikel lesen | |
| 13.11.23 | e-therapeutics - More to come in RNAi therapy discovery | 385 | Edison Investment Research | e-therapeutics reported H1 FY24 results (to end-July 2023), reaffirming its commitment to integrating its computational and hepatocyte biology expertise to develop short interfering RNA (siRNA) therapies.... ► Artikel lesen | |
| 13.11.23 | Carr's Group - A new team to take the group forward | 327 | Edison Investment Research | Carr's Group has announced a fully refreshed executive team, none having been in-situ at the start of 2023. This will enable the executives to have an uninhibited view of the operations, enabling the... ► Artikel lesen |
| Suchbegriffe der letzen 24 h | Anzahl |
|---|---|
| EVOTEC | 326 |
| BAYER | 254 |
| BYD | 172 |
| NEL | 166 |
| DEUTSCHE BANK | 162 |
| TUI | 156 |
| NVIDIA | 142 |
| TESLA | 142 |
| RHEINMETALL | 134 |
| RWE | 132 |
| PLUG POWER | 128 |
| MERCEDES-BENZ | 123 |
| APPLE | 120 |
| SUPER MICRO COMPUTER | 113 |
| DEUTSCHE LUFTHANSA | 112 |
| BERKSHIRE HATHAWAY | 109 |
| PALANTIR TECHNOLOGIES | 103 |
| XIAOMI | 97 |
| AMAZON | 95 |
| VOLKSWAGEN | 92 |
| AIXTRON SE | 90 |
| BASF | 84 |
| COMMERZBANK | 81 |
| RENK GROUP | 81 |
| SIEMENS ENERGY | 78 |
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und
